Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124204) titled 'Evaluation of Biodistribution, Radiation Dosimetry, and Safety of 68Ga-EV203 Injection in Patients with Hematologic Malignancies: A Translational Clinical Study' on May 8.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
Multiple myeloma (MM), non-Hodgkin lymphoma (NHL), or acute myeloid leukemia (AML)
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-05-08
Target Sample Size: Experimental group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=322074
Published b...